McKesson is a pharmaceutical wholesaler and healthcare distribution company. The European Commission described McKesson Corporation in a 2023 decision as a pharmaceutical wholesale and retail company providing logistics and services in the healthcare sector.1

What the sources say

McKesson’s own site says that it distributes pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.2 An earlier Commission decision states that McKesson operates in the distribution and delivery of pharmaceuticals and medical equipment, medical supply products, and the delivery of healthcare information technology to healthcare organisations.3

In United States drug supply chain law, a wholesale distributor is a person, other than a manufacturer, a manufacturer’s co-licensed partner, a third-party logistics provider or a repackager, engaged in wholesale distribution.4 That statutory category is the legal frame in which a pharmaceutical wholesaler operates in the United States, though none of the sources opened states which category McKesson falls into.42

Role in the supply chain

McKesson is a Wholesaler in the pharmaceutical chain; see Pharmaceutical Supply Chain and MediLedger. In this vault McKesson is a class under the wholesaler role, not an individual.

What the sources do not establish

Sources give no revenue, customer or market-share figures, and the two Commission descriptions differ in what they emphasise, wholesale and retail in one and distribution and health information technology in the other.13 They also give no list of the countries or product lines in which McKesson operates. The link to MediLedger is a vault relation, and no source opened here describes McKesson’s participation in it.

Footnotes

  1. European Commission, Case M.10404 Phoenix / McKesson, decision of 2023. https://ec.europa.eu/competition/mergers/cases1/202316/M_10404_9151122_703_3.pdf ↩ ↩2

  2. McKesson, About McKesson page. https://www.mckesson.com/about-mckesson/ ↩ ↩2

  3. European Commission, Case M.7818 McKesson / UDG Healthcare (Pharmaceutical Wholesale and Associated Businesses). https://ec.europa.eu/competition/mergers/cases/decisions/m7818_331_3.pdf ↩ ↩2

  4. Cornell Law School Legal Information Institute, “21 U.S. Code § 360eee - Definitions”. https://www.law.cornell.edu/uscode/text/21/360eee ↩ ↩2